Publication | Open Access
Concomitant Cytotoxic Effector Differentiation of CD4+ and CD8+ T Cells in Response to EBV-Infected B Cells
21
Citations
34
References
2022
Year
Most people infected by EBV acquire specific immunity, which then controls latent infection throughout their life. Immune surveillance of EBV-infected cells by cytotoxic CD4<sup>+</sup> T cells has been recognized; however, the molecular mechanism of generating cytotoxic effector T cells of the CD4<b><sup>+</sup></b> subset remains poorly understood. Here we compared phenotypic features and the transcriptome of EBV-specific effector-memory CD4<sup>+</sup> T cells and CD8<sup>+</sup> T cells in mice and found that both T cell types show cytotoxicity and, to our surprise, widely similar gene expression patterns relating to cytotoxicity. Similar to cytotoxic CD8<sup>+</sup> T cells, EBV-specific cytotoxic CD4<sup>+</sup> T cells from human peripheral blood expressed T-bet, Granzyme B, and Perforin and upregulated the degranulation marker, CD107a, immediately after restimulation. Furthermore, T-bet expression in cytotoxic CD4<sup>+</sup> T cells was highly correlated with Granzyme B and Perforin expression at the protein level. Thus, differentiation of EBV-specific cytotoxic CD4<sup>+</sup> T cells is possibly controlled by mechanisms shared by cytotoxic CD8<sup>+</sup> T cells. T-bet-mediated transcriptional regulation may explain the similarity of cytotoxic effector differentiation between CD4<sup>+</sup> T cells and CD8<sup>+</sup> T cells, implicating that this differentiation pathway may be directed by environmental input rather than T cell subset.
| Year | Citations | |
|---|---|---|
Page 1
Page 1